Abstract:Background aims: In this article we aimed to provide an expert synthesis of the current status of Schwann cell (SC)therapeutics and potential steps to increase their clinical utility. Methods: We provide an expert synthesis based on preclinical, clinical and manufacturing experience. Results: Schwann cells (SCs) are essential for peripheral nerve regeneration and are of interest in supporting axonal repair after spinal cord injury (SCI). SCs can be isolated and cultivated in tissue culture from adult nerve biopsies or generated from precursors and neural progenitors using specific differentiation protocols leading to expanded quantities. In culture, they undergo dedifferentiation to a state similar to "repair" SCs. The known repertoire of SC functions is increasing beyond axon maintenance, myelination, and axonal regeneration to include immunologic regulation and the release of potentially therapeutic extracellular vesicles. Recently, autologous human SC cultures purified under cGMP conditions have been tested in both nerve repair and subacute and chronic SCI clinical trials. Although the effects of SCs to support nerve regeneration are indisputable, their efficacy for clinical SCI has been limited according to the outcomes examined. Conclusions: This review discusses the current limitations of transplanted SCs within the damaged spinal cord environment. Limitations include limited post-transplant cell survival, the inability of SCs to migrate within astrocytic parenchyma, and restricted axonal regeneration out of SC-rich graft regions. We describe steps to amplify the survival and integration of transplanted SCs and to expand the repertoire of uses of SCs, including SC-derived extracellular vesicles. The relative merits of transplanting autologous versus allogeneic SCs and the role that endogenous SCs play in spinal cord repair are described. Finally, we briefly describe the issues requiring solutions to scale up SC manufacturing for commercial use.

Engineered Schwann Cell-Based Therapies for Injury Peripheral Nerve Reconstruction

Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy

Tissue engineering with peripheral blood-derived mesenchymal stem cells promotes the regeneration of injured peripheral nerves

Biomaterial-Based Schwann Cell Transplantation and Schwann Cell-Derived Biomaterials for Nerve Regeneration

Therapeutic strategies for peripheral nerve injury: decellularized nerve conduits and Schwann cell transplantation

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Schwann Cell-Like Cells: Origin and Usability for Repair and Regeneration of the Peripheral and Central Nervous System

Augmenting Peripheral Nerve Regeneration with Adipose-Derived Stem Cells

Insights Into the Role and Potential of Schwann Cells for Peripheral Nerve Repair From Studies of Development and Injury

Biomaterials for Peripheral Nerve Injury Repair

Hybrid construction of tissue-engineered nerve graft using skin derived precursors induced neurons and Schwann cells to enhance peripheral neuroregeneration

Engineered neural tissue with Schwann cell differentiated human dental pulp stem cells: potential for peripheral nerve repair?

Challenges in advancing Schwann cell transplantation for spinal cord injury repair

[Repairing Peripheral Nerve Defects by Tissue Engineering Techniques:An Experimental Study].

Application of stem cells in peripheral nerve regeneration

Repair of the Injured Spinal Cord by Schwann Cell Transplantation

Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration

Scaffolds for Peripheral Nerve Repair and Reconstruction

Tissue Engineering for the Repair of Peripheral Nerve Injury

Bone marrow mesenchymal stem cells in treatment of peripheral nerve injury

Biohacking Nerve Repair: Novel Biomaterials, Local Drug Delivery, Electrical Stimulation, and Allografts to Aid Surgical Repair